UV Radiation Inhibits 15-Hydroxyprostaglandin Dehydrogenase Levels in Human Skin: Evidence of Transcriptional Suppression

Elevated levels of prostaglandins (PG) have been detected in the skin following UV radiation (UVR). PGs play an important role in mediating both the acute and the chronic consequences of UVR exposure. UVR-mediated induction of cyclooxygenase-2 (COX-2) contributes to increased PG synthesis. In theory, reduced catabolism might also contribute to increased PG levels. 15-Hydroxyprostaglandin deyhdrogenase (15-PGDH), a tumor suppressor gene, plays a major role in PG catabolism. In this study, we investigated whether UVR exposure suppressed 15-PGDH while inducing COX-2 in keratinocytes and in human skin. UVR exposure caused dose-dependent induction of COX-2, suppression of 15-PGDH, and increased prostaglandin E2 (PGE2) production in HaCaT cells. Exposure to UVR suppressed the transcription of 15-PGDH, resulting in reduced 15-PGDH mRNA, protein, and enzyme activities. UVR exposure induced Slug, a repressive transcription factor that bound to the 15-PGDH promoter. Silencing Slug blocked UVR-mediated downregulation of 15-PGDH. The effects of UVR were also evaluated in the EpiDerm skin model, a three-dimensional model of human epidermis. Here too, COX-2 levels were induced and 15-PGDH levels suppressed following UVR exposure. Next, the effects of UVR were evaluated in human subjects. UVR treatment induced COX-2 while suppressing 15-PGDH mRNA in the skin of 9 of 10 subjects. Collectively, these data suggest that reduced expression of 15-PGDH contributes to the elevated levels of PGs found in the skin following UVR exposure. Possibly, agents that prevent UVR-mediated downregulation of 15-PGDH will affect the acute or the long-term consequences of UVR exposure, including nonmelanoma skin cancer. Cancer Prev Res; 3(9); 1104–11. ©2010 AACR.

[1]  R. DuBois,et al.  Eicosanoids and cancer , 2010, Nature Reviews Cancer.

[2]  S. Reddy,et al.  Absence of Myeloid COX-2 Attenuates Acute Inflammation but Does Not Influence Development of Atherosclerosis in Apolipoprotein E Null Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[3]  C. McCulloch,et al.  Basal Cell Carcinoma Chemoprevention with Nonsteroidal Anti-inflammatory Drugs in Genetically Predisposed PTCH1+/− Humans and Mice , 2010, Cancer Prevention Research.

[4]  D. Tobin,et al.  The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  H. Tai,et al.  Bile acids inhibit NAD+-dependent 15-hydroxyprostaglandin dehydrogenase transcription in colonocytes. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[6]  R. Yantiss,et al.  NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase Regulates Levels of Bioactive Lipids in Non–Small Cell Lung Cancer , 2008, Cancer Prevention Research.

[7]  D. Kusewitt,et al.  The acute cutaneous inflammatory response is attenuated in Slug-knockout mice , 2008, Laboratory Investigation.

[8]  D. Alberts,et al.  Cross‐validation of Murine UV Signal Transduction Pathways in Human Skin † , 2008, Photochemistry and photobiology.

[9]  J. Rundhaug,et al.  Cyclo‐oxygenase‐2 Plays a Critical Role in UV‐induced Skin Carcinogenesis † , 2008, Photochemistry and photobiology.

[10]  K. Müller-Decker,et al.  The cyclooxygenase‐2‐mediated prostaglandin signaling is causally related to epithelial carcinogenesis , 2007, Molecular carcinogenesis.

[11]  K. Chun,et al.  A proposed COX‐2 and PGE2 receptor interaction in UV‐exposed mouse skin , 2007, Molecular carcinogenesis.

[12]  D. Carbone,et al.  Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer. , 2007, Cancer research.

[13]  H. Tai,et al.  Pioglitazone and Rosiglitazone Decrease Prostaglandin E2 in Non–Small-Cell Lung Cancer Cells by Up-Regulating 15-Hydroxyprostaglandin Dehydrogenase , 2007, Molecular Pharmacology.

[14]  J. Rundhaug,et al.  Cyclooxygenase‐2 expression is critical for chronic UV‐induced murine skin carcinogenesis , 2007, Molecular carcinogenesis.

[15]  Changsun Choi,et al.  Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes , 2007, Molecular carcinogenesis.

[16]  K. Chun,et al.  Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4. , 2007, Cancer research.

[17]  A. Almudevar,et al.  Deletion of prostaglandin E2 EP2 receptor protects against ultraviolet-induced carcinogenesis, but increases tumor aggressiveness. , 2007, The Journal of investigative dermatology.

[18]  S. Narumiya,et al.  Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors , 2007, Laboratory Investigation.

[19]  Li Xu,et al.  Endogenous Prostaglandins E2 and F2α Serve as an Anti-Apoptotic Factor against Apoptosis Induced by Tumor Necrosis Factor-α in Mouse 3T3-L1 Preadipocytes , 2006 .

[20]  T. P. Pretlow,et al.  15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis , 2006, Proceedings of the National Academy of Sciences.

[21]  B. Karlan,et al.  15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. , 2006, Cancer research.

[22]  S. Dey,et al.  Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[23]  大谷 泰介 Levels of NAD[+]-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease : evidence for involvement of TNF-α , 2006 .

[24]  D. Kusewitt,et al.  Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development. , 2006, The Journal of investigative dermatology.

[25]  D. Whiteman,et al.  Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. , 2005, Journal of the American Academy of Dermatology.

[26]  S. Fischer,et al.  Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development. , 2005, Cancer research.

[27]  H. Tai,et al.  NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. , 2004, Carcinogenesis.

[28]  K. Subbaramaiah,et al.  Microsomal Prostaglandin E Synthase-1 Is Overexpressed in Inflammatory Bowel Disease , 2004, Journal of Biological Chemistry.

[29]  K. Subbaramaiah,et al.  Targeting cyclooxygenase-2 in human neoplasia: rationale and promise. , 2003, Cancer cell.

[30]  L. Kopelovich,et al.  Cyclooxygenases in the skin: pharmacological and toxicological implications. , 2003, Toxicology and applied pharmacology.

[31]  D. Kusewitt,et al.  Inhibition of cutaneous ultraviolet light B–mediated inflammation and tumor formation with topical celecoxib treatment , 2003, Molecular carcinogenesis.

[32]  S. Ullrich,et al.  Ultraviolet radiation-induced immunosuppression of delayed-type hypersensitivity in mice. , 2002, Methods.

[33]  H. Tai,et al.  Prostaglandin catabolizing enzymes. , 2002, Prostaglandins & other lipid mediators.

[34]  D. Dunson,et al.  Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. , 2002, Cancer research.

[35]  L. Audoly,et al.  Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus , 2002, Nature Medicine.

[36]  G. T. Bowden,et al.  Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes , 2001, Oncogene.

[37]  T. Oberyszyn,et al.  Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. , 2000, Prostaglandins & other lipid mediators.

[38]  H. Tai,et al.  Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. , 2000, Biochemical and biophysical research communications.

[39]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[40]  J. Schoggins,et al.  Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. , 1999, Carcinogenesis.

[41]  K. Seibert,et al.  Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis , 1999, Molecular carcinogenesis.

[42]  D. Bickers,et al.  Reconstituted 3-dimensional human skin as a novel in vitro model for studies of carcinogenesis. , 1999, Biochemical and biophysical research communications.

[43]  J. Masferrer,et al.  COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. , 1998, Carcinogenesis.

[44]  J. Krueger,et al.  Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. , 1997, Archives of dermatology.

[45]  F. Pichaud,et al.  Chromosomal localization of the type-I 15-PGDH gene to 4q34–q35 , 1997, Human Genetics.

[46]  K. Subbaramaiah,et al.  Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. , 1996, Cancer research.

[47]  H. Tai,et al.  15-Hydroxyprostaglandin dehydrogenase. , 1995, Journal of lipid mediators and cell signalling.

[48]  S. Ullrich,et al.  Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. , 1992, Journal of immunology.

[49]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[50]  R. Daynes,et al.  Involvement of prostaglandins in the immune alterations caused by the exposure of mice to ultraviolet radiation. , 1986, Journal of immunology.

[51]  R. Camp,et al.  Novel prostaglandin dehydrogenase in rat skin. , 1983, The Biochemical journal.

[52]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.